Johns Hopkins HIV Guide
Nelfinavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 12, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Nelfinavir." Johns Hopkins HIV Guide, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir.
Auwaerter PG, Pham PA. Nelfinavir. Johns Hopkins HIV Guide. 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir. Accessed September 28, 2023.
Auwaerter, P. G., & Pham, P. A. (2023). Nelfinavir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir
Auwaerter PG, Pham PA. Nelfinavir [Internet]. In: Johns Hopkins HIV Guide. ; 2023. [cited 2023 September 28]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nelfinavir
ID - 545144
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2023/08/12/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
